These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 410705)

  • 21. Fixed drug eruption from chlorphenesin carbamate.
    Coskey RJ
    JAMA; 1982 Jul; 248(1):30-1. PubMed ID: 6211558
    [No Abstract]   [Full Text] [Related]  

  • 22. GLC determination of chlorphenesin carbamate in serum.
    Kaiser DG; Shaw SR
    J Pharm Sci; 1974 Jul; 63(7):1094-7. PubMed ID: 4852199
    [No Abstract]   [Full Text] [Related]  

  • 23. Selective induction of phase II drug metabolizing enzyme activities by quinolines and isoquinolines.
    Le HT; Franklin MR
    Chem Biol Interact; 1997 Mar; 103(3):167-78. PubMed ID: 9134007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative pharmacokinetics of chlorphenesin carbamate and methocarbamol in man.
    Forist AA; Judy RW
    J Pharm Sci; 1971 Nov; 60(11):1686-8. PubMed ID: 5133920
    [No Abstract]   [Full Text] [Related]  

  • 25. High-pressure liquid chromatographic determination of chlorphenesin carbamate and the beta-isomeric carbamate.
    Beyer WF
    J Pharm Sci; 1976 Dec; 65(12):1802-5. PubMed ID: 1032666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of rat liver drug-metabolizing enzymes by heterocycle-containing mono-, di-, tri- and tetra-arylmethanes.
    Franklin MR
    Biochem Pharmacol; 1993 Aug; 46(4):683-9. PubMed ID: 8363642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of 1-benzylimidazole on cytochromes P-450 induction and on the activities of epoxide hydrolases and UDP-glucuronosyltransferases in rat liver.
    Magdalou J; Totis M; Boiteux-Antoine AF; Fournel-Gigleux S; Siest G; Schladt L; Oesch F
    Biochem Pharmacol; 1988 Sep; 37(17):3297-304. PubMed ID: 2840913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of hepatic cytochrome P-450c-dependent monooxygenase activities by dantrolene in rat.
    Jayyosi Z; Totis M; Souhaili H; Goulon-Ginet C; Livertoux MH; Batt AM; Siest G
    Biochem Pharmacol; 1987 Aug; 36(15):2481-7. PubMed ID: 3111484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective changes in cytochrome P-450 and UDP-glucuronosyltransferase subpopulations following partial hepatectomy in rats.
    Iversen PL; Liu Z; Franklin MR
    Toxicol Appl Pharmacol; 1985 Mar; 78(1):10-8. PubMed ID: 3929423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validated liquid chromatography-tandem mass spectrometry method for determination of totally nine probe metabolites of cytochrome P450 enzymes and UDP-glucuronosyltransferases.
    Lee JT; Pao LH; Hsiong CH; Huang PW; Shih TY; Yoa-Pu Hu O
    Talanta; 2013 Mar; 106():220-8. PubMed ID: 23598120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of hepatic drug-metabolizing enzymes induced by 3-methylcholanthrene and phenobarbital between pre- and postnatal rats.
    Sunouchi M; Takanaka A; Mizokami K; Inoue K; Fujimori K; Kasuya Y; Omori Y
    Toxicol Appl Pharmacol; 1984 May; 73(3):457-63. PubMed ID: 6326348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of methylmercury on hypnotic action of hexobarbital, liver hydroxylase and cytochrome P-450 in mice.
    Su MQ; Okita GT
    Toxicology; 1986 Jun; 39(3):233-45. PubMed ID: 3705086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decrease in serum thyroxine level by phenobarbital in rats is not necessarily dependent on increase in hepatic UDP-glucuronosyltransferase.
    Kato Y; Suzuki H; Ikushiro S; Yamada S; Degawa M
    Drug Metab Dispos; 2005 Nov; 33(11):1608-12. PubMed ID: 16049124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of age and sex on the inducibility of hepatic microsomal 4-nitrophenol UDP-glucuronyltransferase activity in rats.
    Zhu BT; Suchar LA; Gwynne M; Huang MT
    Life Sci; 1995; 57(1):PL19-24. PubMed ID: 7596214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of murine gamma-interferon on the mouse liver and its drug-metabolizing enzymes: comparison with human hybrid alpha-interferon.
    Franklin MR; Finkle BS
    J Interferon Res; 1985; 5(2):265-72. PubMed ID: 3925033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decrease in the activity of the drug-metabolizing enzymes of rat liver following the administration of tilorone hydrochloride.
    Leeson GA; Biedenbach SA; Chan KY; Gibson JP; Wright GJ
    Drug Metab Dispos; 1976; 4(3):232-8. PubMed ID: 6227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Metabolic interactions of promethazine (author's transl)].
    Pfeifer S; Borchert HH; Schuster S; Schulz H
    Pharmazie; 1981 Dec; 36(12):815-8. PubMed ID: 6799969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies on the influence of piprozoline on the microsomal enzyme system of the rat liver (author's transl)].
    Friedrich G; Vollmer KO
    Arzneimittelforschung; 1977; 27(2b):517-9. PubMed ID: 577415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of dietary sulfur-containing amino acids on the activity of drug-metabolizing enzymes in rat-liver microsomes.
    Magdalou J; Steimetz D; Batt AM; Poullain B; Siest G; Debry G
    J Nutr; 1979 May; 109(5):864-71. PubMed ID: 108366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of four hypolipidaemic agents on the activity of drug-metabolizing enzymes in rat liver microsomes.
    Fournel S; Magdalou J; Batt AM; Siest G
    Int J Clin Pharmacol Res; 1983; 3(6):431-6. PubMed ID: 6432712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.